An article reporting a reversal of Alzheimer’s symptoms has captured the attention of science journalists around the globe.

The case report, published in the Journal of Neuroinflammation, describes a dramatic reversal of Alzheimer’s symptoms in a patient following treatment using the anti-tumor necrosis factor-alpha (TNF) therapeutic, etanercept.

Coverage has included a 3 minute broadcast feature  on CNN, with newspaper reports spanning the world from the Daily Telegraph and Daily Mail to the Australian Herald Sun, and web coverage including ScienceDaily, Ars Technica and Slashdot.

Matt McKay
Head of PR, BioMed Central